Daily Roundup

JLG.ASX CU6.ASX ABB.ASX CAT.ASX SMP.ASX

Scheme Now Effective and Suspension of Trading on ASX

Johns Lyng Group Limited (JLG) has some big news - the scheme of arrangement between the company and its shareholders has been approved by the Supreme Court and is now legally effective. Under the scheme, Sherwood BidCo Pty Ltd will acquire 100% of JLG's shares. As a result, trading in JLG shares on the ASX will be suspended from the close of trading on October 14, 2025.

Co-PSMA Trial Achieves Primary Endpoint

Over at Clarity Pharmaceuticals, their Co-PSMA Investigator-Initiated Trial has hit a major milestone. The trial demonstrated that Clarity's diagnostic product, 64Cu-SAR-bisPSMA, detects significantly more prostate cancer lesions per patient compared to the standard-of-care 68Ga-PSMA-11 PET/CT, especially in patients with low prostate-specific antigen (PSA) levels. These results support the potential for 64Cu-SAR-bisPSMA to improve early detection and staging of prostate cancer, which could lead to better treatment decisions and outcomes for patients.

Aussie Broadband Delivers Strong FY25 Results

Aussie Broadband has reported impressive financial results for the 2025 fiscal year. Revenue grew 18.7% to $1.2 billion, with underlying EBITDA reaching $138.2 million. The company also signed a 6-year wholesale agreement with More Telecom, adding 290,000 connections, and launched its new Nitrogen wholesale platform to support the migration. Aussie Broadband remains focused on its 'Look-to-28' strategy, aiming to grow revenue beyond $1.6 billion and capture an 11%+ share of the NBN market by 2028.

Catapult Completes $130M Institutional Placement

Turning to Catapult Sports, the company has successfully completed a fully underwritten $130 million institutional placement. The funds will be used to acquire IMPECT GmbH, a leading soccer analytics software company, and strengthen Catapult's balance sheet. Catapult is also offering a Share Purchase Plan of up to $20 million to eligible shareholders in Australia and New Zealand, as well as US-resident directors.

Smartpay Shareholders to Vote on $1.20 Scheme

Finally, Smartpay Holdings has announced a $1.20 per share scheme of arrangement with Shift4 Holdings Limited. The Smartpay Board unanimously recommends that shareholders vote in favor of the scheme, as it represents a significant premium to the pre-announcement share price. Shareholders will have the opportunity to realize certain value for their Smartpay shares in cash. The scheme is expected to complete in early November 2025, subject to shareholder and court approval.